...
首页> 外文期刊>Archives of disease in childhood >Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection.
【24h】

Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection.

机译:在社区获得性尿路感染中细菌对口服抗生素的敏感性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The most common oral antibiotics used in the treatment of urinary tract infection (UTI) are sulphonamides and cephalosporins, but emerging resistance is not unusual. AIMS: To assess the change in susceptibility of urinary pathogens to oral antibiotics during the past decade in children with community acquired UTI. METHODS: The study sample included two groups of children with a first community acquired UTI: 142 children enrolled in 1991 and 124 enrolled in 1999. UTI was diagnosed by properly collected urine specimen (suprapubic aspiration, transurethral catheterisation, or midstream specimen in circumcised males) in symptomatic patients. Antimicrobial susceptibility of the isolates was compared between the two groups. RESULTS: The pathogens recovered in the two groups were similar: in 1991--E coli 86%, Klebsiella 6%, others 8%; in 1999--E coli 82%, Klebsiella 13%, and others 5%. A slight but generalised decrease in bacterial susceptibility to common antibiotics in the two groups was shown: ampicillin 35% versus 30%; cephalexin 82% versus 63% (p < 0.001); nitrofurantoin 93% versus 92%. The only exception was co-trimoxazole, 60% versus 69%. Overall resistance to antibiotics in 1999 was as follows: ampicillin 70%, cephalexin 37%, co-trimoxazole 31%, amoxicillin-clavulanate 24%, nitrofurantoin 8%, cefuroxime-axetil 5%, nalidixic acid 3%. CONCLUSIONS: This study shows a slight but generalised decrease in bacterial susceptibility to common oral antibiotics in the past decade in our population. Empirical initial treatment with co-trimoxazole or cephalexin is inadequate in approximately one third of UTI cases. A larger number of pathogens may be empirically treated with amoxicillin-clavulanate (24% resistance); 95% of organisms are susceptible to cefuroxime-axetil.
机译:背景:用于治疗尿路感染(UTI)的最常见口服抗生素是磺胺类药物和头孢菌素,但新出现的耐药性并不罕见。目的:评估过去十年来社区获得性尿路感染儿童的尿道病原体对口服抗生素的敏感性变化。方法:研究样本包括两组儿童,他们是第一个社区获得性尿道感染的:1991年入组的142名儿童和1999年入院的124例。通过适当收集的尿液样本(耻骨上抽吸,经尿道导管插入术或经割礼的男性中游标本)诊断出尿道感染。在有症状的患者中。在两组之间比较了分离物的抗菌敏感性。结果:两组的病原体相似:1991年:大肠杆菌86%,克雷伯菌6%,其他8%。 1999年:大肠杆菌82%,克雷伯菌13%,其他5%。两组的细菌对普通抗生素的敏感性略有普遍下降:氨苄西林35%比30%;氨苄西林35%比30%。头孢氨苄82%对63%(p <0.001);呋喃妥因为93%,而呋喃妥因为92%。唯一的例外是复方新诺明,分别为60%和69%。 1999年对抗生素的总体耐药性如下:氨苄西林70%,头孢氨苄37%,联苯三唑31%,阿莫西林-克拉维酸24%,呋喃妥因8%,头孢呋辛酯-AXETIL 5%,萘啶酸3%。结论:这项研究表明,在过去的十年中,我们的人群对普通口服抗生素的细菌敏感性略有但普遍下降。在大约三分之一的尿路感染病例中,用三甲恶唑或头孢氨苄进行经验性的初始治疗是不够的。大量病原体可用阿莫西林-克拉维酸盐治疗(24%耐药); 95%的生物易感染头孢呋辛酯。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号